by Jordana Choucair | Apr 28, 2022 | Life Sciences
Moderna asked the Food and Drug Administration (FDA) to grant an emergency use authorization for its COVID-19 vaccine in children 6 months to under 6 years of age. Moderna said last month its COVID-19 vaccine for children — which consists of two 25-microgram doses —...
by Jordana Choucair | Apr 28, 2022 | Opioid/Substance Use Disorders
Members of the House Oversight and Reform Committee questioned McKinsey & Company about its potential role in exacerbating the opioid epidemic. The hearing comes after the committee released a report alleging a years-long conflict of interest stemming from...
by Jordana Choucair | Apr 28, 2022 | Payers
According to a new report from Moody’s Investors Service, insurers have a significant opportunity to drive mental and behavioral health costs down. The report notes that private insurance accounts for 27.7 percent of emergency department visits across the five...
by Jordana Choucair | Apr 28, 2022 | Payers
The U.S. Health and Human Services Department Office of the Inspector General (OIG) released a report indicating that Medicare Advantage plans improperly deny millions of reimbursement claims and authorization requests for medically necessary care. The OIG found...
by Jordana Choucair | Apr 28, 2022 | Public Health/Prevention
Dr. Anthony Fauci said that the U.S.is in a “transition phase” of the COVID-19 pandemic. He noted that while COVID-19 cases and hospitalizations are trending up again, it’s not anywhere near the rise we saw over the winter with the Omicron wave and that fewer...
Recent Comments